Vertical transmission of HIV-1 risk and prevention in pregnant women;Verticale HIV-1-transmissie. I. Risico's en preventie bij de zwangere

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 50, 1998, Pages 2720-2724

  Orendi, J M ^a   Boer, K ^a   Van Loon, A M ^a   Borleffs, J C C ^a   Van Oppen, A C C ^a   Boucher, C A B ^a  

^a Academisch Zickenhuis Utrecht   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ANTIVIRUS AGENT;

ADULT; CESAREAN SECTION; DRUG RESISTANCE; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INFECTION PREVENTION; PRENATAL DIAGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS REPLICATION; VIRUS TRANSMISSION; ADOLESCENT; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; DRUG COMBINATION; FETOMATERNAL TRANSFUSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; NEWBORN; PATHOGENICITY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; THIRD TRIMESTER PREGNANCY; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT; VIRAL LOAD;

EID: 0032512138     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994:331:1173-80.
2. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis 1994;170:1134-40.
3. Bryson YJ. Perinatal HIV-1 transmission: recent advances and therapeutic interventions. AIDS 1996:10 Suppl 3:S33-42.
4. Boer K, Mulder-Kampinga GA, Scherpbier HJ. HIV en zwangerschap. Ned Tijdschr Geneeskd 1995:139:970-5.
5. Scherpbier HJ, Mulder-Kampinga GA, Bol P, Boer K. HIV-infectie en AIDS bij kinderen. Ned Tijdschr Geneeskd 1995:139:975-9.
6. Orendi JM, Geelen SPM, Graeff-Meeder ER de, Loon AM van, Schuurman R, Boucher CAB. Verticale HIV-1-transmissie. II. HIV-diagnostiek bij het kind. Ned Tijdschr Geneeskd 1998:142:2724-8.
7. Newell ML, Dunn DT, Peckham CS, Semprini AE, Pardi G, Giaquinto C, et al. Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996:10:1675-81.
8. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996:275:599-605.
9. Borkowsky W, Krasinski K, Cao Y, Ho D, Pollack H, Moore T, et al. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 1994:125:345-51.
10. Fang G, Burger H, Crimson R, Tropper P, Nachman S, Mayers D, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995:92:12100-4.
11. Coll O, Hernandez M, Boucher CAB, Fortuny C, De Tejada BM, Canct Y, et al. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J Acquir Immune Defic Syndr Hum Retrovirol 1997:14:27-30.
12. Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mandelbrot L, Ciraru-Vigneron N, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997:175:172-5.
13. Zollner B, Feucht HH, Helling-Giese G, Schroter M, Laufs R. HIV quantification: useful for prediction of vertical transmission? Lancet 1996:347:899.
14. Mandelbrot L, Mayaux MJ, Bongain A, Berrebi A, Moudoub-Jeanpetit Y, Benifla JL, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996:175(3 Pt I):661-7.
15. Mandelbrot L, Brossard Y, Aubin JT, Bignozzi C, Krivine A, Simon F, et al. Testing for in utero human immunodeficiency virus infection with fetal blood sampling. Am J Obstet Gynecol 1996:175:489-93.
16. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr 1995:126:625-32.
17. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, et al. Estimated timing of mother-to-child human immunodeficiency virus type (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol 1995:142:1330-7.
18. Tovo PA, De Martino M, Gabiano C, Galli L, Cappello N, Ruga E, et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. Italian Register for HIV Infection in Children. J Acquir Immune Defic Syndr Hum Retrovirol 1995:11:88-94.
19. Kuhn L, Bobat R, Coutsoudis A, Moodley D, Coovadia HM, Tsai WY, et al. Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acquir Immune Defic Syndr Hum Retrovirol 1996:11:478-83.
20. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N EngI J Med 1996:335:1621-9.
21. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, et al. Obstetrical factors and the transmission of human immuno-deficiency virus type from mother to child. The Women and Infants Transmission Study. N EngI J Med 1996:334:1617-23.
22. Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J, Handelsman E, et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr 1996:129:198-207.
23. Newell ML, Dunn D, De Maria A, Ferrazin A, De Rossi A, Giaquinto C, et al. Detection of virus in vertically exposed HIV-antibody-negative children. Lancet 1996;347:213-5.
24. Rouse DJ, Owen J, Goldenberg RL, Vormund SH. Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach. J Acquir Immune Defic Syndr Hum Retrovirol 1995:9:401-7.
25. Frenkel LM, Cowles MK, Shapiro DE, Melvin AJ, Walts DH, McLellan C, et al. Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 1997:175:971-4.
26. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol 1997;176:478-89.
27. Lewis LL, Venzon D, Church J, Parley M, Wheeler S, Keller A, et al. Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group. J Infect Dis 1996;147:16-25.